Vaxcyte (PCVX) | Stock Overview & Key Data

What is PCVX's 52-week high and low?

In the last 52 weeks, Vaxcyte reached a high of $121.06 (on September 19, 2024) and a low of $27.66 (on April 10, 2025).

What is the market cap and P/E ratio for PCVX?

Curious about Vaxcyte's size and valuation? Its market capitalization stands at 4.40B. When it comes to valuation, the P/E ratio (trailing twelve months) is -8.97, and the forward P/E (looking ahead) is -7.24.

Does PCVX pay dividends? If so, what's the yield?

As for dividends, Vaxcyte isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Vaxcyte's main competitors or similar companies to consider before investing?

When looking at Vaxcyte, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	114.06B	Healthcare	Biotechnology	-3.15%	56.18%
Regeneron REGN	55.27B	Healthcare	Biotechnology	-47.08%	-11.94%
Blueprint Medicines BPMC	8.29B	Healthcare	Biotechnology	14.91%	126.85%
Roivant Sciences ROIV	7.82B	Healthcare	Biotechnology	3.19%	127.07%
Bio-Techne TECH	7.92B	Healthcare	Biotechnology	-25.62%	-42.54%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Vaxcyte Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Vaxcyte's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -19.66%, the Debt to Equity ratio from the most recent quarter is 2.73, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for PCVX?

Looking at Vaxcyte's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of PCVX stock is held by insiders and institutions?

Wondering who owns Vaxcyte stock? Company insiders (like executives and directors) hold about 0.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 117.63%.

For more common questions about our data, please visit our About Data page.